News & Updates

Plasma microRNAs disturbed in Alzheimer’s disease
Plasma microRNAs disturbed in Alzheimer’s disease
29 Sep 2022

Patients with Alzheimer’s disease (AD) show slightly dysregulated levels of plasma microRNAs (miRNA), including miRNA-92a-3p and miRNA-29a-3p, a recent study has found.

Plasma microRNAs disturbed in Alzheimer’s disease
29 Sep 2022
Telepsychiatry as reliable as face-to-face interviews for symptom assessment
Telepsychiatry as reliable as face-to-face interviews for symptom assessment
29 Sep 2022 byKanas Chan

Assessments of depressive, anxiety and psychotic symptoms and suicidal risk by telepsychiatry have good reliability in general when compared with face-to-face interviews, according to researchers from the Queen Mary Hospital (QMH).

Telepsychiatry as reliable as face-to-face interviews for symptom assessment
29 Sep 2022
Adjuvant pembrolizumab continues to improve DFS in clear cell RCC
Adjuvant pembrolizumab continues to improve DFS in clear cell RCC
28 Sep 2022 byRoshini Claire Anthony

In patients with clear cell renal cell carcinoma (RCC), adjuvant pembrolizumab continues to improve disease-free survival (DFS) over placebo, according to extended follow-up of the phase III KEYNOTE-564 trial.

Adjuvant pembrolizumab continues to improve DFS in clear cell RCC
28 Sep 2022
Vision impairment tied to depression, anxiety in children
Vision impairment tied to depression, anxiety in children
28 Sep 2022 byStephen Padilla

Children with vision impairment are at higher risk of developing symptoms of depression and anxiety, according to a study, noting that surgical treatment of strabismus may improve these symptoms.

Vision impairment tied to depression, anxiety in children
28 Sep 2022